Metronomic chemotherapy for cancer treatment: a decade of clinical studies

被引:0
作者
Adriana Romiti
M. Christina Cox
Ida Sarcina
Roberta Di Rocco
Chiara D’Antonio
Viola Barucca
Paolo Marchetti
机构
[1] Sapienza University,Department of Oncology, Faculty of Medicine and Psychology
[2] Sant’Andrea Hospital,Department of Hematology, Faculty of Medicine and Psychology
[3] Sapienza University,undefined
[4] Sant’Andrea Hospital,undefined
来源
Cancer Chemotherapy and Pharmacology | 2013年 / 72卷
关键词
Metronomic chemotherapy; Cancer therapy; “Continuous low dose” chemotherapy; Solid tumours;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:13 / 33
页数:20
相关论文
共 50 条
[41]   Metronomic chemotherapy in non-small cell lung cancer [J].
Shu, Yefei ;
Weng, Shanshan ;
Zheng, Song .
ONCOLOGY LETTERS, 2020, 20 (06)
[42]   A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer [J].
Roberto, Michela ;
Romiti, Adriana ;
Onesti, Concetta E. ;
D'Antonio, Chiara ;
Milano, Annalisa ;
Falcone, Rosa ;
Barucca, Viola ;
Palombi, Lucia ;
Righini, Riccardo ;
Marchetti, Paolo .
ANTI-CANCER DRUGS, 2016, 27 (02) :106-111
[43]   Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology [J].
Petrucci, Goncalo N. ;
Magalhaes, Tomas Rodrigues ;
Dias, Marcia ;
Queiroga, Felisbina Luisa .
FRONTIERS IN VETERINARY SCIENCE, 2024, 11
[44]   The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy [J].
Ekici, D. ;
Kargi, A. ;
Yalcin, A. Didem ;
Savas, B. .
JOURNAL OF BUON, 2013, 18 (01) :245-252
[45]   Metronomic Chemotherapy in Elderly Patients [J].
Arianna Bandini ;
Pasquale Fabio Calabrò ;
Marta Banchi ;
Paola Orlandi ;
Guido Bocci .
Current Oncology Reports, 2024, 26 :359-376
[46]   Metronomic chemotherapy: an antiangiogenic scheduling [J].
B. Laquente ;
F. Viñals ;
J. R. Germà .
Clinical and Translational Oncology, 2007, 9 :93-98
[47]   Metronomic chemotherapy and tumor immunomodulation [J].
Bernacki, Ralph J. .
CANCER BIOLOGY & THERAPY, 2008, 7 (04) :602-602
[48]   Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy [J].
Perroud, Herman A. ;
Alasino, Carlos M. ;
Rico, Maria J. ;
Queralt, Francisco ;
Pezzotto, Stella M. ;
Rozados, Viviana R. ;
Scharovsky, O. Graciela .
FUTURE ONCOLOGY, 2016, 12 (10) :1233-1242
[49]   Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation [J].
Bocci, G ;
Tuccori, M ;
Emmenegger, U ;
Liguori, V ;
Falcone, A ;
Kerbel, RS ;
Del Tacca, M .
ANNALS OF ONCOLOGY, 2005, 16 (08) :1243-1252
[50]   Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy [J].
Sales, Maria E. ;
Espanol, Alejandro J. ;
Salem, Agustina R. ;
Pulido, Paola M. ;
Sanchez, Y. ;
Sanchez, Francisco .
CURRENT CLINICAL PHARMACOLOGY, 2019, 14 (02) :91-100